Inhibition of murine erythroid colony formation in vitro by interferon gamma and correction by interferon receptor

R T Means1, S B Krantz, J Luna

  • 1Hematology Division, Vanderbilt University School of Medicine, Nashville, TN.

Blood
|February 15, 1994
PubMed

Insights

Interferon gamma (IFN gamma) inhibits erythroid colony formation in mice, an effect reversed by erythropoietin (EPO) or an IFN gamma receptor (IFN gamma R-IgG). This study establishes an in vitro animal model for IFN gamma's impact on red blood cell production.

Area of Science:

  • Hematology
  • Immunology
  • Virology

Background:

  • Interleukin-1 (IL-1) indirectly inhibits human erythroid colony-forming units (CFU-E) via interferon gamma (IFN gamma).
  • IFN gamma directly inhibits CFU-E, with effects counteracted by high erythropoietin (EPO) concentrations.

Purpose of the Study:

  • To establish an in vitro animal model for studying IFN gamma inhibition of erythropoiesis.
  • To investigate the effects of recombinant murine (rm) IFN gamma on purified murine CFU-E.

Main Methods:

  • Studied rmIFN gamma effects on CFU-E from Friend virus anemia (FVA)-infected mice.
  • Assessed rmIFN gamma inhibition and its reversal by high EPO concentrations.
  • Utilized a soluble murine IFN gamma receptor-IgG (mIFN gamma R-IgG) to block rmIFN gamma activity.

Main Results:

  • rmIFN gamma inhibited large CFU-E colonies dose-dependently.
  • High EPO concentrations (64 U/mL) corrected rmIFN gamma inhibition by 72%.
  • mIFN gamma R-IgG dose-dependently corrected rmIFN gamma inhibition, with near complete correction at 0.5 nmol/L.

Conclusions:

  • An in vitro animal model for IFN gamma-induced erythropoiesis inhibition was developed.
  • IFN gamma R-IgG effectively neutralized IFN gamma's inhibitory effects on murine CFU-E.
  • IFN gamma R-IgG shows potential for mitigating IFN gamma toxicity in vivo.